User

Survival Predictors of People Living with HIV/ AIDS in Wamena, Papua

Tena Kogoya, Argyo Demartoto, Bhisma Murti

Abstract

Background: Quality of life (QoL) is an important component in the evaluation of the well-being of people living with HIV and AIDS (PLWHA), especially with the appreciable rise in the longevity of PLWHA. The analysis of the quality of life is essential for the healthcare policies and services directed toward PLWHA, since this indicator values the perception of people about their own life and health. However, little is known about the determinant of QoL in PLWHA in Papua. The aim of this study was to analyze survival predictors of people living with HIV/ AIDS in Wamena, Papua, Indonesia.

Subjects and Method: This was a retrospective cohort study conducted in Wamena Hospital, Papua, from December 2017 to February 2018. A cohort of 304 PLWHA was selected for this study from the medical record at Wamena Hospital. The dependent variable was survival. The independent variables were adherence to ART, nutritional status, age, and coinfection. The data were collected from medical record and questionnaire. The data were analyzed by Cox regression model.

Results: The risk of dying of PLWHA if adherent to take the ART was lower than not adherent to take the ART (HR=0.45; 95% CI= 0.06 to 0.33; p= 0.002).The risk of dying of PLWHA with poor nutritional status was higher than good nutritional status (HR= 12.78; 95% CI= 6.81 to 23.98; p< 0.001). The risk of dying of PLWHA aged ≥35 years was slightly higher than <35 years (HR= 1.47; 95% CI= 1.00 to 2.17; p= 0.050). The risk of dying of PLWHA with coinfected was higher than without coinfected (HR= 1.59; 95% CI= 1.15 to 2.23; p= 0.006).

Conclusion: The risk of dying of PLWHA decreases if adherent to take the ART, but increases with poor nutritional status, age ≥35 years, and coinfection.

Keywords: survival, adherence to treatment, people living with HIV/ AIDS.

Correspondence: Tena Kogoya. Masters Program in Public Health, Universitas Sebelas Maret, Jl. Ir. Sutami No. 36 A, 57126, Surakarta, Central Java. Email: tena.kogoya76@gmail.com. Phone: +628198869665. 

Indonesian Journal of Medicine (2017), 3(2): 184-191
https://doi.org/10.26911/theijmed.2017.02.03.06

Full Text:

PDF

References

Arjun BY, Unnikrishnan B, Ramapuram JT, Thapar R, Mithra P, Kumar N, Madi D et al. (2015) ‘Factors Influencing Quality of Life among People Living with HIV in Coastal South India.’, Journal of the International Association of Providers of AIDS Care.

Arts EJ, Hazuda DJ (2012). HIV 1 antiretroviral drug therapy’, Cold Spring Harbor Perspectives in Medicine, 2(4).

Bacheler LT, Anton ED, Kudish P, Baker D, Bunville J, Krakowski K, Bolling L. et al. (2000) ‘Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy’, Antimicrobial Agents and Chemotherapy, 44(9): 2475–2484.

Boulougoura A, Sereti I (2016) ‘HIV infection and immune activation: The role of coinfections’, Current Opinion in HIV and AIDS, pp. 191–200.

Boyer PL, Sarafianos SG, Arnold E, Hughes SH (2001) ‘Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.’, Journal of Virology, 75(10): 4832–42.

Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, Mori J. (2005) ‘Maraviroc (UK 427,857), a potent, orally bioavailable, and selective small molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity’, Antimicrobial Agents and Chemotherapy, 49(11): 4721–4732.

Dykes C, Fox K, Lloyd A, Chiull Mi, Morse E, Demeter LM. (2001) ‘Impact of clinical reverse transcriptase sequences on the replication capacity of HIV 1 drug-resistant mutants’, Virology, 285(2): 193–203.

Hasanah CI, Zaliha AR, Mahiran M. (2011) ‘Factors influencing the quality of life in patients with HIV in Malaysia’, Quality of Life Research, 20(1), pp. 91–100.

Hendricks KM, Erzen HD, Wanke CA, Tang AM. (2010) ‘Nutrition Issues in the HIV Infected Injection Drug User: Findings from the Nutrition for Healthy Living Cohort’, Journal of the American College of Nutrition, 29(2), pp. 136–143.

Iacob SA, Iacob DG, and Jugulete G. (2017) ‘Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment clinical points of view and practical considerations’, Frontiers in Pharmacology.

KaiserJD, Campa AM, Ondercin JP, Leoung GS, Pless RF, Baum MK. (2006) ‘Micronutrient supplementation increases the CD4 count in HIV infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial.’, Journal of acquired immune deficiency syndromes (1999), 42(5): 523–528.

Kemenkes Republik Indonesia (2016). Situasi penyakit HIV AIDS di Indonesia, Pusat Data dan Informasi Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. (2011) Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral pada Orang Dewasa.

Kirkcaldy EM, Spiegel P, Abdalla F, Erdelmann F (2006) ‘The development of programme strategies for integration of HIV, food and nutrition activities in refugee settings’, UNAIDS Best Practice Collection.

Lalezari JP, Henry K, O'Hearn M, Montaner JSG, Piliero PJ, Trottier B, Walmsley S. et al. (2003) ‘Enfuvirtide, an HIV 1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America’, New England Journal of Medicine, 348(22): 2175–2185.

Lewandowski CM, Coinvestigator N, Lewandowski CM (2015) WHO Glocal tuberculosis report 2015, The effects of a brief mindfulness intervention on acute pain experience: An examination of individual difference.

Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, et al. (2011) ‘Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds’, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 53(8): 817–25.

Naeger LK, Margot NA, Miller MD (2002) ‘ATPdependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase’, Antimicrobial Agents and Chemotherapy, 46(7): 2179–2184.

Oguntibeju OO. (2012) ‘Quality of life of people living with HIV and AIDS and antiretroviral therapy.’, HIV/AIDS (Auckland, N.Z.), 4: 117–24.

Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM. et al. (2000) ‘Adherence to protease inhibitor therapy and outcomes in patients with HIV infection’, Annals of internal medicine, 133(1): 21–30.

Rathbun C (2017) Antiretroviral Therapy for HIV Infection, Medscape.

Riourd ML, Ehresmann C, Parniak MA, Ehresmann B, Marquet R (2002) ‘Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)resistant HIV1 reverse transcriptase: Comparison between initiation and elongation of reverse transcription and between (-) and (+) strand DNA synthesis’, Journal of Biological Chemistry, 277(21): 18611–18618.

Schey KL, Luther JM, Rose KL (2016) ‘HHS Public Access’, 11(5): 1–21.

Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, Kuritzkes DR et al. (2007) ‘HIV1 protease and reverse transcriptase mutations for drug resistance surveillance.’, AIDS (London, England), 21(2): 215–23.

SluisCremer N, Temiz NA, Bahar I (2004) ‘Conformational changes in HIV1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.’, Current HIV research, 2(4): 323–32.

Sullivan ZA, Wong EB, Ndung'u T, Kasprowicz VO, Bishai WR. (2015) ‘Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals CoInfected with HIV’, EBioMedicine, 2(4): 334–340.

UNAIDS (2015) Global Aids Response Progress Reporting 2015, The Lancet.

Unit B, Africa S (2009). ‘Nutritional status, quality of life and CD4 cell count of adults living with HIV/AIDS in the GaRankuwa area (South Africa)’, 22(3): 124–129.

Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA. et al. (2005) ‘Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature, 438(7064): 99–102.

Who and Searo (2008) ‘Regional Consultation on Nutrition and HIV/A IDS: Evidence, lessons and recommendations for action in South East Asia’, in Regional Consultation on Nutrition and HIV/AIDS: Evidence, lessons and recommendations for action in South East Asia , p. 63.

Wilen CB, Tilton JC, Doms RW (2012) ‘Molecular mechanisms of HIV entry’, Advances in Experimental Medicine and Biology, 726: 223–242.

Zanoni BC, Gandhi R T (2014) ‘Update on opportunistic infections in the era of effective antiretroviral therapy’, Infectious Disease Clinics of North America: 501–518.

Refbacks

  • There are currently no refbacks.